Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Harness Therapeutics logo — Unlocking New Targets to Transform the Treatment of Neurodeg...

Harness Therapeutics

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases

Founded 2023 United Kingdom Cambridge, United Kingdom 34 employees Series Unknown Total: $17.70M Biotechnology, Life Sciences

General Information

Company Name Harness Therapeutics
Founded Year 2023
Location United Kingdom Cambridge, United Kingdom +1
Employees 34
Industries Biotechnology, Life Sciences
Funding Stage Series Unknown
Social

Get notified when Harness Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Harness Therapeutics

Harness Therapeutics, founded in 2023, is a pioneering company in the Biotechnology and Life Sciences industries, based in the United Kingdom. The company is dedicated to "Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases", which serves as both its mission and slogan.

As a fresh entrant in the field, Harness Therapeutics has quickly captivated investor interest, evidenced by its latest investment—a Venture Round on January 27, 2025. This round attracted key players like the Dementia Discovery Fund, Epidarex Capital, Ono Venture Investment, and Takeda Pharma. Their backing signals strong faith in the company’s potential to impact the neurodegenerative disease market substantially.

For investors, Harness Therapeutics presents a promising opportunity at the intersection of groundbreaking science and unmet medical needs, with a strategy poised to make significant headway in neurodegenerative therapeutics.

Taxonomy: therapeutic RNAs, SINEUPs, protein upregulation, neurodegenerative diseases, CNS disorders, opthalmologic disorders, druggable proteome, post-transcriptional upregulation, RNA therapeutics, mRNA, ASO (antisense oligonucleotides), novel mechanism of action, biologics, gene therapy

Services & Products

Disease-modifying therapeutics development
Targeted protein modulation
Precision therapies for neurodegenerative disorders
RNA biology research

Target Customers

Patients with neurodegenerative diseases Healthcare providers Pharmaceutical companies Biotechnology researchers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 4
Investor Investor Investor Investor
27 Jan 2025
Seed Round •••••• 1
Investor
28 Nov 2023
Seed Round •••••• 2
Investor Investor
31 May 2022
Seed Round •••••• 2
Investor Investor
01 Jun 2021
Seed Round •••••• 2
Investor Investor
01 Jan 2020

Harness Therapeutics Alternatives & Competitors

View All Alternatives
Harness Therapeutics vs
RNatives
RNatives Finland

Next generation gene therapy company with innovative nuclear microRNA-technology for cardiovascular...

6 employees
Biotechnology, Health Care
Harness Therapeutics vs
The Mind Project
The Mind Project United States

Aiming to tackle the stigma and raise awareness about mental health around the world!

1 employees
Health Care, Health and Wellness
Compare Harness Therapeutics vs The Mind Project
Harness Therapeutics vs
City Sounds of NY- Speech-Language Development Center, Inc.
City Sounds of NY- Speech-Language Development Center, Inc.

"Dedicated to making a child's voice is heard"

73 employees
Also compare with: Harness Therapeutics vs ENT Specialists Inc. ENT Specialists Inc. Harness Therapeutics vs Neurocrine Biosciences Neurocrine Biosciences View all alternatives

FAQ About Harness Therapeutics

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Harness Therapeutics was founded in 2023.
Harness Therapeutics is headquartered in Cambridge, United Kingdom.
Harness Therapeutics operates in the following industries: Biotechnology, Life Sciences.
Harness Therapeutics has approximately 34 employees.
Harness Therapeutics has completed 5 funding rounds, raising a total of $17.70M. The latest funding stage is Series Unknown.
Harness Therapeutics offers: Disease-modifying therapeutics development, Targeted protein modulation, Precision therapies for neurodegenerative disorders, RNA biology research.
Top alternatives and competitors to Harness Therapeutics include RNatives, The Mind Project , City Sounds of NY- Speech-Language Development Center, Inc., SNORE Australia, ENT Specialists Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Harness Therapeutics and RNatives are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Harness Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy